Dendritic cells and immunotherapy for malignant disease.
about
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer modelBiological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy?Blood stem cell transplantation for breast cancer: new approaches using pre- peri- post-transplant immunotherapy.Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.An immunohistochemical study of CD83- and CD1a-positive dendritic cells in the decidua of women with recurrent spontaneous abortion.Dendritic cells and their potential therapeutic role in haematological malignancy.Immunotherapy using dendritic cells against multiple myeloma: how to improve?Cellular immunotherapy using dendritic cells against multiple myelomaDendritic cells in MDS and AML--cause, effect or solution to the immune pathogenesis of disease?Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells.Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells.In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines.Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies.Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia.Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia.Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma.Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemiaSynergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
P2860
Q33689002-4A541266-7F94-4EF5-ACAC-425694020CA2Q34452706-6D954722-C109-4CE5-872F-4C49606F58B7Q34452719-FBAB8BD0-2EFC-4D51-B928-7ADC859F0DC9Q34771278-C71D0D83-423E-459A-B973-772773BB36C4Q34995101-794BC9AF-D3DE-421C-B17E-F1787C110639Q35614625-C6CAAFC5-833A-4716-9C98-B32B008ADEFAQ35852574-723B978F-9976-47AC-B2EC-645CEBF52812Q35865581-6C8AAE60-2664-4C30-9152-E38F90A934CBQ36021493-CAECFA92-7AFF-4E0A-B8A6-CC8372489960Q36545286-1BFF6133-E10A-47B1-8FB2-4364B8F96463Q37336499-75BCEE73-1A6B-49B1-9691-A0188924DCBAQ37823518-D1E9167A-6C58-4352-AEC8-374E3537CA94Q39649359-0BE07A02-CE37-4A8E-9141-0857D489C1CFQ41233921-AC718E08-4CD1-451B-90AA-3817DDD373C7Q44272941-B830543D-ED30-4EB5-B239-CE1F9DEC7C6BQ51795322-3BDD5A4C-7202-4A9F-A53A-AC05BD695B49Q53538542-321823C1-5FB5-4103-B6AD-3CD71FA14F6DQ53585655-C64255B6-901C-4880-BF55-5C5927572C51Q53656699-D5FD0ADB-EE80-440B-A5DA-83BC47614989Q55462347-8E1C851D-4D3B-4E7F-B1E7-3B15952FC552Q58484362-1E2D23EE-BB13-48EE-BA10-354C63651D88Q58801894-91BAE46B-CF28-4237-9ABB-36687E173895
P2860
Dendritic cells and immunotherapy for malignant disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dendritic cells and immunotherapy for malignant disease.
@ast
Dendritic cells and immunotherapy for malignant disease.
@en
Dendritic cells and immunotherapy for malignant disease.
@nl
type
label
Dendritic cells and immunotherapy for malignant disease.
@ast
Dendritic cells and immunotherapy for malignant disease.
@en
Dendritic cells and immunotherapy for malignant disease.
@nl
prefLabel
Dendritic cells and immunotherapy for malignant disease.
@ast
Dendritic cells and immunotherapy for malignant disease.
@en
Dendritic cells and immunotherapy for malignant disease.
@nl
P2860
P1476
Dendritic cells and immunotherapy for malignant disease.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.2001.02626.X
P407
P577
2001-03-01T00:00:00Z